- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage III Squamous Cell Carcinoma of the Head and Neck in Korea, Republic of
Total 314 results
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedHead and Neck NeoplasmKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Yonsei UniversityActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Korea, Republic of
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Samyang Biopharmaceuticals CorporationUnknownHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Yonsei UniversityNot yet recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaTerminatedHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckChina, Korea, Republic of
-
Eisai Inc.PharmaBio Development Inc.CompletedPlatinum-Resistant Squamous Cell Carcinoma of the Head and NeckUnited States, Korea, Republic of, Ukraine, United Kingdom
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of the Head and NeckFrance, United States, Israel, Korea, Republic of, Australia
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Johns Hopkins UniversityCastle Biosciences IncorporatedRecruitingCutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Yonsei UniversityUnknown
-
University Hospital OstravaCompletedSquamous Cell Carcinomas of the Head and NeckCzech Republic
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Korea, Republic of, Spain, Greece, Germany, Japan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; IO BiotechRecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Janssen Research & Development, LLCRecruitingRecurrent/Metastatic Head and Neck Squamous Cell CarcinomaKorea, Republic of, Taiwan, Malaysia, United States
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
EMD SeronoCompletedSquamous Cell Carcinoma of the Head and Neck CancerCzech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
Yonsei UniversityUnknownSquamous Cell Carcinoma of EsophagusKorea, Republic of
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Rain Oncology IncTerminatedMetastatic Head-and-neck Squamous-cell CarcinomaUnited States, Australia
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | Stage... and other conditionsUnited States, Canada, Hong Kong
-
Sensei Biotherapeutics, Inc.TerminatedSquamous Cell Carcinoma of the Head and NeckUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckBrazil, Italy, United Kingdom, United States, Hong Kong, France, Netherlands, Germany, Argentina, Canada, Japan, Korea, Republic of, Spain, Switzerland, Taiwan
-
GlaxoSmithKlineiTeos TherapeuticsRecruitingNeoplasms, Head and NeckUnited States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; Innogene Kalbiotech Pte...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckPhilippines, Thailand, Korea, Republic of, Australia, Taiwan, India, Saudi Arabia, Singapore, South Africa, Egypt, Cuba, Indonesia, Malaysia
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada, France, Italy, Spain, United Kingdom, Poland, Taiwan, Thailand, Vietnam, Belgium, Germany, Korea, Republic of, Brazil, India, Japan, Philippines, Russian Federation, Austria, Ukraine, Greece, Slovakia, Romania
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Korea, Republic of, United Kingdom, Spain, Belgium, Singapore, Canada, Netherlands, Australia